PCVX icon

Vaxcyte
PCVX

Overview Fund Activity

198 hedge funds and large institutions have $3.9B invested in Vaxcyte in 2022 Q4 according to their latest regulatory filings, with 82 funds opening new positions, 91 increasing their positions, 23 reducing their positions, and 9 closing their positions.

Holders
198
Holders Change
+73
Holders Change %
+58.4%
% of All Funds
3.19%
Holding in Top 10
10
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+100%
% of All Funds
0.16%
New
82
Increased
91
Reduced
23
Closed
9
Calls
$25.1M
Puts
$15.6M
Net Calls
+$9.49M
Net Calls Change
+$15.1M

Top Buyers

1
Capital Research Global Investors
1
Capital Research Global Investors
California
$135M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$317M
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$169M
4
BlackRock
4
BlackRock
New York
$245M
5
Jennison Associates
5
Jennison Associates
New York
$68.2M

Top Sellers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$286M
2
A
2
Abingworth
United Kingdom
$96.8M
3
TGA
3
TPG GP A
Texas
$57.1M
4
MVM
4
Medicxi Ventures Management
Jersey
$69.9M
5
National Bank of Canada
5
National Bank of Canada
Quebec, Canada
$23.3M
Name Holding Trade Value Shares
Change 		Shares
Change %
NHAS
26
Novo Holdings A/S
Denmark
$34.8M -$4.73M -98,705 -12%
KCM
27
Kynam Capital Management
New Jersey
$33.7M +$230K +4,803 +0.7%
DM
28
Deerfield Management
New York
$33.6M +$33.6M +700,000 New
PBPIA
29
Pivotal bioVenture Partners Investment Advisor
California
$33.2M -$3.98M -83,000 -11%
PAMS
30
Pictet Asset Management (Switzerland)
Switzerland
$32M +$32M +666,467 New
Northern Trust
31
Northern Trust
Illinois
$31.6M +$8.41M +175,439 +36%
VC
32
Vivo Capital
California
$27.8M +$8.39M +175,000 +43%
PAMP
33
Polar Asset Management Partners
Ontario, Canada
$26.7M +$9.6M +200,200 +56%
Renaissance Technologies
34
Renaissance Technologies
New York
$25M +$20.6M +428,777 +460%
T. Rowe Price Investment Management
35
T. Rowe Price Investment Management
Maryland
$24.5M +$24.5M +511,436 New
Charles Schwab
36
Charles Schwab
California
$23.4M +$6.87M +143,253 +41%
National Bank of Canada
37
National Bank of Canada
Quebec, Canada
$23.3M -$19.2M -400,000 -45%
Goldman Sachs
38
Goldman Sachs
New York
$19.1M -$4.24M -88,519 -18%
SCM
39
Soleus Capital Management
Connecticut
$18.6M +$2.51M +52,300 +16%
CAM
40
Cormorant Asset Management
Massachusetts
$15.6M +$15.6M +325,000 New
Marshall Wace
41
Marshall Wace
United Kingdom
$15.5M +$15.5M +322,600 New
Bank of New York Mellon
42
Bank of New York Mellon
New York
$14.8M +$6.14M +128,078 +71%
Point72 Asset Management
43
Point72 Asset Management
Connecticut
$14.5M -$5.76M -120,200 -28%
TCM
44
Tang Capital Management
California
$14.4M +$14.4M +300,000 New
Bank of America
45
Bank of America
North Carolina
$14.2M +$9.12M +190,164 +179%
Nuveen Asset Management
46
Nuveen Asset Management
Illinois
$12.3M +$3.21M +66,864 +35%
JPMorgan Chase & Co
47
JPMorgan Chase & Co
New York
$12.1M +$3.49M +72,805 +40%
Voloridge Investment Management
48
Voloridge Investment Management
Florida
$12M +$12M +251,186 New
IC
49
Ikarian Capital
Texas
$12M +$12M +250,000 New
WP
50
Woodline Partners
California
$12M +$2.57M +53,571 +27%
1
2
3 4 5